Dr. L. Claes - gynaecologie - verloskunde
0699.848.763 · rovalta.com · 28/09/2026
ACTIVE
Dr. L. Claes - gynaecologie - verloskunde
Financial year 2025 · Closed on 30/06/2025
Net result73,5 k €-10,1 %over 1 year
Gross margin112,4 k €-7,7 %over 1 year
Equity144,7 k €-24,3 %over 1 year
Overview
Identity
Source · BCE/KBODr. L. Claes - gynaecologie - verloskunde is a Private limited company incorporated in 2018. Its main activity is: Specialist medical practice activities. Its registered office is in Glabbeek.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0699.848.763
- Incorporation
- 11/07/2018
- Legal form
- Private limited company
- Registered office
- Ruekenbosstraat 18A
3380 Glabbeek · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 30/06/2025
Activities (NACE)
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 7 filingsTrend over 7 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 112,4 k € | -7.7% | 121,8 k € | -6.9% | 130,8 k € | +31.1% | 99,8 k € | -19.0% | 123,2 k € |
| EBITDA | 100 k € | -17.5% | 121,2 k € | -7.2% | 130,5 k € | +31.9% | 99 k € | -19.2% | 122,4 k € |
| Operating result | 93,1 k € | -12.4% | 106,3 k € | -12.5% | 121,5 k € | +24.0% | 97,9 k € | -19.8% | 122,1 k € |
| Net result | 73,5 k € | -10.1% | 81,7 k € | -12.1% | 93 k € | +22.0% | 76,2 k € | -20.2% | 95,5 k € |
| Balance sheet | |||||||||
| Equity | 144,7 k € | -24.3% | 191,3 k € | +12.8% | 169,6 k € | -4.0% | 176,6 k € | -39.4% | 291,4 k € |
| Total assets | 278,1 k € | -3.0% | 286,8 k € | -9.4% | 316,4 k € | +25.3% | 252,4 k € | -17.6% | 306,4 k € |
| Cash | 110,5 k € | -20.8% | 139,5 k € | +4.1% | 134 k € | -10.8% | 150,1 k € | -33.1% | 224,5 k € |
| Debts | 133,4 k € | +39.7% | 95,5 k € | -35.0% | 146,8 k € | +93.9% | 75,7 k € | +407% | 14,9 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
See the valuationBoard of directors
Source · NBB, accounts to 30/06/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Lieselotte Claes | DirectorAdministrator - managerendedManagerended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 |
| Closing of the financial year | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 27/01/2026 | 19/12/2024 | 29/12/2023 | 28/12/2022 | 30/12/2021 | 25/01/2021 |
| General meeting | 11/12/2025 | 06/12/2024 | 01/12/2023 | 02/12/2022 | 03/12/2021 | 07/12/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 7 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/06/2025 | 11/12/2025 | 27/01/2026 | Dutch | |
| Micro model | 30/06/2024 | 06/12/2024 | 19/12/2024 | Dutch | |
| Micro model | 30/06/2023 | 01/12/2023 | 29/12/2023 | Dutch | |
| Micro model | 30/06/2022 | 02/12/2022 | 28/12/2022 | Dutch | |
| Micro model | 30/06/2021 | 03/12/2021 | 30/12/2021 | Dutch | |
| Micro model | 30/06/2020 | 07/12/2020 | 25/01/2021 | Dutch | |
| Micro model | 30/06/2019 | 06/12/2019 | 16/12/2019 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Lieselotte Claes | DirectorAdministrator - managerendedManagerended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings7 filings
201820192020202120222023202420252026
Dr. L. Claes - gynaecologie - verloskunde
Ruekenbosstraat 18 bte A, 3380 Glabbeek (Zuurbemde)
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Ruekenbosstraat 18A, 3380 Glabbeek (Zuurbemde)Current | CBE | |
| Ruekenbosstraat 18 bte A, 3380 Glabbeek (Zuurbemde) | accounts 2022 → 2025 | Accounts 2025 · 2026-00014817 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Dr. L. Claes - gynaecologie - verloskundeCurrent | accounts 2022 → 2025 | Accounts 2025 · 2026-00014817 |
Events
- 2025Annual accounts 202573,5 k €↓
- 2024Annual accounts 202481,7 k €↓
- 2023Annual accounts 202393 k €↑
- 2022Annual accounts 202276,2 k €↓
- 2021Annual accounts 202195,5 k €↑
- 2020Annual accounts 202076 k €↓
- 2019Annual accounts 2019101,3 k €
- 11/07/2018IncorporationPrivate limited company